Alphatec Holdings, Inc.
Could not find a ticker for this position, may be a filing error
A designer and seller of spinal implants, fixation systems, biologics, and surgical instruments for treating spine disorders, Alphatec centers its lineup on the Prone TransPsoas (PTP) lateral approach, SafeOp nerve monitoring, and an imaging-and-robotics platform built on EOS whole-body scans and Valence surgical navigation. The company began in 1990 as a contract manufacturer for other medical-device firms, renamed itself Alphatec Spine in 2005 to mark its shift to its own spine products, and later folded EOS imaging into its platform in 2021.
0.75% Convertible Senior Notes due 2026
Sold 100.0K
Granted 14.42M
Sold 750.0K
Sold 100.0K
Bought 58.7K · Sold 750.0K
Granted 6.75M · Sold 1.70M
Bought 238.8K · Sold 338.8K
Granted 6.73M · Sold 9.30M
Granted 6.73M · Sold 9.30M
Granted 1.47M · Bought 9.12M · Sold 1.00M
Sold 750.0K
Granted 10.08M · Bought 127.5K · Sold 2.33M
Granted 22.50M · Bought 6.89M · Sold 9.42M
Granted 2.22M
Granted 626.2K · Bought 7.5K · Sold 630.1K
Granted 3.78M · Bought 15.0K · Sold 1.85M
Granted 572.0K · Bought 8.0K
Granted 23.86M · Bought 6.71M · Sold 9.46M
Granted 119.6K · Bought 80.6K · Sold 8.7K
Granted 10.0K · Bought 17.8K
Granted 1.33M · Sold 749.5K
Granted 746.8K · Bought 9.0K · Sold 61.4K
Granted 702.8K · Bought 48.0K
Granted 1.26M · Bought 5.0K · Sold 493.6K
Granted 632.7K · Bought 20.0K
Granted 731.1K · Sold 285.5K
Granted 713.0K · Bought 97.0K · Sold 51.8K
Granted 460.9K · Bought 100.0K
Granted 1.69M · Bought 11.0K · Sold 1.03M
Granted 221.6K · Bought 120.0K · Sold 30.0K
Granted 505.0K · Sold 220.0K
Granted 11.3K · Bought 120.0K
Granted 90.3K · Bought 174.0K
Bought 180.0K
Granted 250.0K · Bought 30.0K
Granted 125.0K
Granted 25.0K · Bought 60.0K
Granted 118.8K · Bought 20.0K
Granted 125.7K · Bought 9.0K
Granted 112.2K · Bought 30.0K
Granted 112.2K
Bought 10.0K
Granted 143.0K · Sold 48.3K
Granted 120.5K · Sold 28.1K
Granted 10.0K · Bought 14.5K · Sold 7.0K
Granted 172.0K · Bought 255.0K
Granted 74.4K · Bought 10.0K
Granted 131.1K · Bought 71.8K · Sold 50.0K
Bought 59.0K
Bought 30.0K
Granted 59.1K
Granted 58.8K · Bought 13.8K
Granted 46.3K
Granted 58.3K · Sold 17.3K
Granted 37.3K
Granted 136.1K · Bought 5.0K
Bought 32.0K
Granted 10.0K · Bought 20.0K
Granted 15.0K
Bought 9.0K
Granted 112.2K
Bought 5.8K
Bought 2.2K
Bought 444
Granted 18.5K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| HGP II, LLC10% owner · 2 transactions | — | 42.12Mas of Nov 2012 | — | — | 100.0K |
| Healthpointcapital Partners II L P +1 co-filerDirector, 10% owner · 1 transaction | — | 22.45Mas of Mar 2010 | 14.42M | — | — |
| Squadron Capital Holdings LLC10% owner · 4 transactions | — | 21.79M | — | — | 750.0K |
| Healthpointcapital Partners II L P10% owner · 1 transaction | — | 21.01Mas of Nov 2012 | — | — | 100.0K |
| Pritzker Jennifer N.10% owner · 44 transactions | — | 13.47M | — | 58.7K | 750.0K |
| Segal Paul +1 co-filer10% owner, Director by deputization, 10% owner · 12 transactions | — | 11.08Mas of May 2023 | 6.75M | — | 1.70M |
| Segal PaulDirector · 8 transactions | — | 11.08Mas of Mar 2024 | — | 238.8K | 338.8K |
| HGP LLC10% owner · 5 transactions | — | 10.78Mas of Nov 2012 | 6.73M | — | 9.30M |
| HealthpointCapital Partners LP10% owner · 5 transactions | — | 10.78Mas of Nov 2012 | 6.73M | — | 9.30M |
| Pelizzon David RDirector · 24 transactions | — | 10.77M | 1.47M | 9.12M | 1.00M |
| Squadron Capital LLC10% owner · 4 transactions | — | 10.65M | — | — | 750.0K |
| Miles PatrickCEO, Director · 82 transactions | — | 6.04M | 10.08M | 127.5K | 2.33M |
| Foster John10% owner · 19 transactions | — | 2.65Mas of Dec 2016 | 22.50M | 6.89M | 9.42M |
| Woods Ward W JrDirector · 14 transactions | — | 2.21Mas of Jun 2025 | 2.22M | — | — |
| Tullis James L LDirector · 63 transactions | — | 1.74Mas of Feb 2024 | 626.2K | 7.5K | 630.1K |
| Hunsaker Craig EEVP, PEOPLE & CULTURE · 96 transactions | — | 1.73M | 3.78M | 15.0K | 1.85M |
| Rich TerryPresident & COO, Director · 7 transactions | — | 1.42Mas of Aug 2018 | 572.0K | 8.0K | — |
| Berkowitz Mortimer IIIDirector · 34 transactions | — | 1.26M | 23.86M | 6.71M | 9.46M |
| Bakst EvanDirector · 15 transactions | — | 1.16Mas of Aug 2024 | 119.6K | 80.6K | 8.7K |
| Hiscock RonaldPresident and CEO · 7 transactions | — | 969.5Kas of Nov 2006 | 10.0K | 17.8K | — |
| Lish ScottCHIEF OPERATING OFFICER · 52 transactions | — | 815.7K | 1.33M | — | 749.5K |
| Black Jeffrey G.EVP & CFO · 17 transactions | — | 670.6Kas of Mar 2021 | 746.8K | 9.0K | 61.4K |
| Snider BrianEVP, MARKETING · 23 transactions | — | 655.4Kas of Aug 2022 | 702.8K | 48.0K | — |
| Koning John ToddCHIEF FINANCIAL OFFICER · 31 transactions | — | 600.7K | 1.26M | 5.0K | 493.6K |
| Blackford Quentin S.Director · 15 transactions | — | 600.4K | 632.7K | 20.0K | — |
| Chubb Corp10% owner · 2 transactions | — | 584.0Kas of Jun 2006 | — | — | — |
| Federal Insurance Co10% owner · 2 transactions | — | 584.0Kas of Jun 2006 | — | — | — |
| Marshall Tyson EliotGENERAL COUNSEL & CORP. SEC. · 26 transactions | — | 574.5K | 731.1K | — | 285.5K |
| Kuyper DirkPresident and CEO, Director · 32 transactions | — | 559.1Kas of Aug 2011 | 713.0K | 97.0K | 51.8K |
| Howell Kelli MariEVP, CLINICAL STRATEGIES · 15 transactions | — | 540.1Kas of Aug 2022 | 460.9K | 100.0K | — |
| Sponsel DavidEVP, SALES · 63 transactions | — | 504.9K | 1.69M | 11.0K | 1.03M |
| Demski David MDirector · 10 transactions | — | 431.6K | 221.6K | 120.0K | 30.0K |
| Yoshimi ShunshiroPres. and CEO of ATEC Pacific · 1 transaction | — | 419.0Kas of Jun 2007 | — | — | — |
| Rydin Jeffrey PDirector · 14 transactions | — | 385.4K | 505.0K | — | 220.0K |
| Asai MitsuoPresident, Alphatec Pacific · 14 transactions | — | 276.6Kas of Nov 2015 | 11.3K | 120.0K | — |
| Valentine KeithDirector · 8 transactions | — | 264.3K | 90.3K | 174.0K | — |
| Hochschuler StephenDirector · 6 transactions | — | 232.2Kas of Aug 2010 | — | 180.0K | — |
| Plunkett Michael JosephPresident and COO · 9 transactions | — | 200.1Kas of Aug 2017 | 250.0K | 30.0K | — |
| Allen JonathanEVP, Commerical Operations · 1 transaction | — | 200.0Kas of Mar 2018 | 125.0K | — | — |
| Ryan PatrickCOO and President, Int'l. · 3 transactions | — | 166.5Kas of Aug 2013 | 25.0K | 60.0K | — |
| O'Neill MichaelChief Financial Officer · 9 transactions | — | 138.7Kas of May 2016 | 118.8K | 20.0K | — |
| Williams Donald AllenDirector · 8 transactions | — | 134.7Kas of Jun 2021 | 125.7K | 9.0K | — |
| GLYNN James RDirector · 8 transactions | — | 127.2Kas of Feb 2015 | 112.2K | 30.0K | — |
| Desai Rohit MDirector · 4 transactions | — | 112.2Kas of Feb 2015 | 112.2K | — | — |
| Romanoski VickySenior VP, CAO and Sec. · 6 transactions | — | 103.0Kas of Nov 2006 | — | 10.0K | — |
| McGinnis Karen KDirector · 11 transactions | — | 94.7K | 143.0K | — | 48.3K |
| Mowry David HDirector · 10 transactions | — | 92.4Kas of Sep 2023 | 120.5K | — | 28.1K |
| Northcutt TrentVP, Sales · 2 transactions | — | 88.6Kas of Jun 2006 | — | — | — |
| Lubischer StephenVP, Sales · 12 transactions | — | 86.5Kas of Nov 2012 | 10.0K | 14.5K | 7.0K |
| Cross Leslie HDirector · 19 transactions | — | 84.4Kas of Apr 2017 | 172.0K | 255.0K | — |
| Hochberg JasonDirector · 7 transactions | — | 84.4Kas of Dec 2021 | 74.4K | 10.0K | — |
| Molson R IanDirector · 11 transactions | — | 78.1Kas of Jun 2017 | 131.1K | 71.8K | 50.0K |
| Corbett JamesPresident and CEO, Director · 6 transactions | — | 77.1Kas of May 2016 | — | 59.0K | — |
| Bellucci Herbert JVP, Manufactuing & Intl. · 2 transactions | — | 76.1Kas of Nov 2006 | — | 30.0K | — |
| Meynadier MarieDirector · 4 transactions | — | 59.1Kas of Jun 2023 | 59.1K | — | — |
| Weise ScottVP, Business Dev. & Marketing · 1 transaction | — | 55.5Kas of Jun 2006 | — | — | — |
| Garner EbunGeneral Counsel and SVP · 33 transactions | — | 48.5Kas of Dec 2016 | 58.8K | 13.8K | — |
| Steven ReineckeVP, Research & Development · 1 transaction | — | 46.3Kas of Oct 2006 | — | — | — |
| Faulstick Luke TDirector · 2 transactions | — | 46.3Kas of Jul 2013 | 46.3K | — | — |
| Altman Elizabeth AnnDirector · 6 transactions | — | 41.1Kas of Jun 2023 | 58.3K | — | 17.3K |
| Davis Tom CDirector · 2 transactions | — | 37.3Kas of May 2015 | 37.3K | — | — |
| Oneil StephenDirector · 8 transactions | — | 33.0Kas of Apr 2017 | 136.1K | 5.0K | — |
| Stott Kermit P.VP, Operations · 8 transactions | — | 25.4Kas of Nov 2010 | — | — | — |
| Wulff Peter CCFO, VP and Treasurer · 6 transactions | — | 22.0Kas of Aug 2010 | — | 32.0K | — |
| Ravitch RichardDirector · 3 transactions | — | 20.0Kas of Nov 2008 | 10.0K | 20.0K | — |
| Plotkin BrianVP, Information Technology · 1 transaction | — | 19.8Kas of Jun 2006 | — | — | — |
| Nelson DennisVP, Finance and Controller · 1 transaction | — | 16.5Kas of Dec 2016 | 15.0K | — | — |
| Timm Jens PeterVP, Research and Development · 5 transactions | — | 13.3Kas of Nov 2010 | — | 9.0K | — |
| Bradshaw KimberlyVP, Physician Services · 1 transaction | — | 11.0Kas of Jun 2006 | — | — | — |
| Marshall Siri SDirector · 4 transactions | — | 6.6Kas of Dec 2016 | 112.2K | — | — |
| Yasbek StevenCFO, VP and Treas. · 1 transaction | — | 5.8Kas of Nov 2006 | — | 5.8K | — |
| Dixon Stephen T DCFO, VP and Treasurer · 1 transaction | — | 2.2Kas of Jun 2006 | — | 2.2K | — |
| Lacienski DanielExecutive VP, Operations · 1 transaction | — | 444as of Jun 2006 | — | 444 | — |
| Barnett AndyDirector · 1 transaction | — | 0as of Jun 2022 | 18.5K | — | — |
| HCPII Co-Invest Vehicle II, L.P.10% owner · 1 transaction | — | 0as of Mar 2012 | — | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -26.00M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.